{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:52:39Z","timestamp":1787169159110,"version":"build-2736575974"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF2020R1C1C1009091"],"award-info":[{"award-number":["NRF2020R1C1C1009091"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF2020R1A2C1011455"],"award-info":[{"award-number":["NRF2020R1A2C1011455"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There are few studies on medical conditions associated with the development of drug-resistant TB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We investigated the risk factors for the occurrence of multidrug-resistant (MDR) tuberculosis (TB) in patients with pulmonary TB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Based on claims data from the Health Insurance Review and Assessment service in South Korea, we retrospectively investigated patients aged 18\u2009years or older with active pulmonary TB who were treated with anti-TB therapy between January 1, 2008, and February 28, 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 248,176 patients with pulmonary TB who underwent anti-TB therapy, 2.0% were identified as having MDR-TB. MDR-TB showed male predominance compared to patients without MDR-TB, and patients with MDR-TB were younger. The risk for MDR-TB in patients treated with anti-TB therapy was 3.26 times higher in patients who received anti-tumor necrosis factor (TNF) agents before prescription of anti-TB medications than in those who had never been exposed to anti-TNF agents after adjusting for other TB risk factors (age, sex, inhaled corticosteroid, diabetes mellitus, liver disease, pneumoconiosis, and organ or blood recipients). The risk for MDR-TB was also increased in males and younger patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Treatment with an anti-TNF agent could be a driver of MDR-TB in patients with pulmonary TB.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2023.1108119","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T01:15:42Z","timestamp":1679447742000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk for multidrug-resistant tuberculosis in patients treated with anti-tumor necrosis factor agents"],"prefix":"10.3389","volume":"10","author":[{"given":"Jinkyeong","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoonki","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Young","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"key":"ref1","volume-title":"Global Tuberculosis Report 2022","year":"2022"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1056\/NEJMoa1108789","article-title":"National survey of drug-resistant tuberculosis in China","volume":"366","author":"Zhao","year":"2012","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1164\/rccm.201909-1874ST","article-title":"Treatment of drug-resistant tuberculosis. An official ATS\/CDC\/ERS\/IDSA clinical practice guideline","volume":"200","author":"Nahid","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e0270003","DOI":"10.1371\/journal.pone.0270003","article-title":"Risk factors for multidrug-resistant tuberculosis: a worldwide systematic review and meta-analysis","volume":"17","author":"Xi","year":"2022","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"368","DOI":"10.4314\/ahs.v15i2.9","article-title":"Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State","volume":"15","author":"Mulu","year":"2015","journal-title":"Afr Health Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/phn.12582","article-title":"Risk factors of multidrug-resistant tuberculosis in China: a meta-analysis","volume":"36","author":"Feng","year":"2019","journal-title":"Public Health Nurs"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e71867","DOI":"10.1371\/journal.pone.0071867","article-title":"Primary drug-resistant tuberculosis in Hanoi, Viet Nam: present status and risk factors","volume":"8","author":"Hang","year":"2013","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/thx.2005.045963","article-title":"Risk factors for multidrug resistant tuberculosis in Europe: a systematic review","volume":"61","author":"Faustini","year":"2006","journal-title":"Thorax"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1056\/NEJM199806043382301","article-title":"Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-international union against tuberculosis and lung disease working group on anti-tuberculosis drug resistance surveillance","volume":"338","author":"Pablos-Mendez","year":"1998","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"800","DOI":"10.5588\/ijtld.12.0628","article-title":"Age, nutritional status and INH acetylator status affect pharmacokinetics of anti-tuberculosis drugs in children","volume":"17","author":"Ramachandran","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e105214","DOI":"10.1371\/journal.pone.0105214","article-title":"Development of multidrug resistant tuberculosis in Bangladesh: a case-control study on risk factors","volume":"9","author":"Rifat","year":"2014","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.1038\/s41598-018-23344-z","article-title":"Comorbidities and treatment outcomes in multidrug resistant tuberculosis: a systematic review and meta-analysis","volume":"8","author":"Samuels","year":"2018","journal-title":"Sci Rep"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e044349","DOI":"10.1136\/bmjopen-2020-044349","article-title":"Risk factors for drug-resistant tuberculosis, the association between comorbidity status and drug-resistant patterns: a retrospective study of previously treated pulmonary tuberculosis in Shandong, China, during 2004-2019","volume":"11","author":"Tao","year":"2021","journal-title":"BMJ Open"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"525","DOI":"10.5588\/ijtld.14.0739","article-title":"Changes in treatment outcomes of multidrug-resistant tuberculosis","volume":"19","author":"Kwak","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ijid.2014.12.016","article-title":"Tuberculosis and chronic respiratory disease: a systematic review","volume":"32","author":"Byrne","year":"2015","journal-title":"Int J Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/s41423-021-00694-9","article-title":"Reactivation of latent tuberculosis with TNF inhibitors: critical role of the beta 2 chain of the IL-12 receptor","volume":"18","author":"Robert","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e79431","DOI":"10.1371\/journal.pone.0079431","article-title":"Mycobacterium tuberculosis-specific TNF-alpha is a potential biomarker for the rapid diagnosis of active tuberculosis disease in Chinese population","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"599386","DOI":"10.3389\/fcimb.2021.599386","article-title":"Screening for mycobacterium tuberculosis infection using Beijing\/K strain-specific peptides in a school outbreak cohort","volume":"11","author":"Hong","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.26355\/eurrev_201802_14389","article-title":"Study on the relationship between changes of immune cells and TNF-\u03b1 in peripheral blood of patients with multidrug-resistant and extensively drug-resistant tuberculosis","volume":"22","author":"Song","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1159\/000283687","article-title":"Association of antigen-stimulated release of tumor necrosis factor-alpha in whole blood with response to chemotherapy in patients with pulmonary multidrug-resistant tuberculosis","volume":"80","author":"Eum","year":"2010","journal-title":"Respiration"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S1473-3099(03)00545-0","article-title":"Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management","volume":"3","author":"Gardam","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"eabh2841","DOI":"10.1126\/science.abh2841","article-title":"Tumor necrosis factor induces pathogenic mitochondrial ROS in tuberculosis through reverse electron transport","volume":"376","author":"Roca","year":"2022","journal-title":"Science"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"612675","DOI":"10.3389\/fmicb.2021.612675","article-title":"Evolution of drug-resistant mycobacterium tuberculosis strains and their adaptation to the human lung environment","volume":"12","author":"Allue-Guardia","year":"2021","journal-title":"Front Microbiol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2810606","DOI":"10.1155\/2017\/2810606","article-title":"Mycobacterium tuberculosis multidrug-resistant strain M induces low IL-8 and inhibits TNF-alpha secretion by bronchial epithelial cells altering neutrophil effector functions","volume":"2017","author":"Kviatcovsky","year":"2017","journal-title":"Mediat Inflamm"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"6654220","DOI":"10.1155\/2021\/6654220","article-title":"Leukocytes from patients with drug-sensitive and multidrug-resistant tuberculosis exhibit distinctive profiles of chemokine receptor expression and migration capacity","volume":"2021","author":"Ocana-Guzman","year":"2021","journal-title":"J Immunol Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.12659\/MSM.904309","article-title":"Association of immune factors with drug-resistant tuberculosis: a case-control study","volume":"23","author":"Sun","year":"2017","journal-title":"Med Sci Monit"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/jac\/dkx506","article-title":"Evolution of drug resistance in mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care","volume":"73","author":"Dookie","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1136\/ard.2009.118935","article-title":"Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology biologics register (BSRBR)","volume":"69","author":"Dixon","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1002\/art.24632","article-title":"Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French research axed on tolerance of biotherapies registry","volume":"60","author":"Tubach","year":"2009","journal-title":"Arthritis Rheum"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1086\/383317","article-title":"Granulomatous infectious diseases associated with tumor necrosis factor antagonists","volume":"38","author":"Wallis","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.jinf.2018.10.004","article-title":"Risk factors of multidrug-resistant tuberculosis: a global systematic review and meta-analysis","volume":"77","author":"Pradipta","year":"2018","journal-title":"J Infect"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1016\/j.jid.2018.01.039","article-title":"Risk of serious infection, opportunistic infection, and herpes zoster among patients with psoriasis in the United Kingdom","volume":"138","author":"Takeshita","year":"2018","journal-title":"J Invest Dermatol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1108119\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T01:15:45Z","timestamp":1679447745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1108119\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":32,"alternative-id":["10.3389\/fmed.2023.1108119"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1108119","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,22]]},"article-number":"1108119"}}